Identification of Putative Markers That Predict the In Vitro Senescence of Mesenchymal Progenitor Cells
Mesenchymal progenitor cells (MPCs) are a promising cell source for regenerative medicine because of their immunomodulatory properties, anti-inflammatory molecule secretion, and replacement of damaged cells. Despite these advantages, heterogeneity in functional potential and limited proliferation ca...
Main Authors: | Eun-Young Shin, Yeo-Joon Yoon, Jeoung Eun Lee, Sung Han Shim, Gene Hong Park, Dong Ryul Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/6/1301 |
Similar Items
-
In search of elixir: Pharmacological agents against stem cell senescence
by: Hourieh Tousian, et al.
Published: (2021-07-01) -
Stepwise combined cell transplantation using mesenchymal stem cells and induced pluripotent stem cell-derived motor neuron progenitor cells in spinal cord injury
by: Jang-Woon Kim, et al.
Published: (2024-04-01) -
Use of human intra-tissue stem/progenitor cells and induced pluripotent stem cells for hair follicle regeneration
by: Manabu Ohyama
Published: (2019-02-01) -
Rheb1-Deficient Neutrophils Promote Hematopoietic Stem/Progenitor Cell Proliferation via Mesenchymal Stem Cells
by: Juan Gao, et al.
Published: (2021-05-01) -
GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells
by: Madison McGrath, et al.
Published: (2019-01-01)